Home/BioGene Therapeutics/Dr. Francis Tavares, PhD.
DF

Dr. Francis Tavares, PhD.

Chief Technology Officer

BioGene Therapeutics

BioGene Therapeutics Pipeline

DrugIndicationPhase
Undisclosed bLNP-Gene TherapyDiabetes (Type 1/2)Preclinical